Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Emulate, Inc.

Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies
From Emulate, Inc.
Via Business Wire
Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications
From Emulate, Inc.
Via Business Wire
Emulate Publishes Novel Framework to Pave the Way for the Integration of Liver-Chip Technology into Pharmaceutical Safety Assessment
From Emulate, Inc.
Via Business Wire
Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets
From Emulate, Inc.
Via Business Wire
Emulate Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
From Emulate, Inc.
Via Business Wire
Emulate Announces Inaugural Global MPS Day and Virtual Symposium to Raise Awareness of Animal Model Alternatives in Scientific Research
From Emulate, Inc.
Via Business Wire
Emulate Publishes Landmark Study Validating Organ-on-a-Chip Technology for Predictive Toxicology in Preclinical Development
From Emulate, Inc.
Via Business Wire
Emulate Announces New Gene Therapy Application Enabling Accelerated Development of Treatments for Genetic Diseases with Organ-on-a-Chip Technology
From Emulate, Inc.
Via Business Wire
Emulate Announces Launch of Immune Cell Recruitment Application for the Colon Intestine-Chip to Aid in the Study of Inflammatory Bowel Disease
From Emulate, Inc.
Via Business Wire
Emulate Announces Promotion of Dr. Lorna Ewart to Chief Scientific Officer
From Emulate, Inc.
Via Business Wire
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
From Emulate, Inc.
Via Business Wire
The Emulate Brain-Chip Ranked #4 on The Scientist's Top 10 Innovations List for 2021
From Emulate, Inc.
Via Business Wire
Emulate Recognized in the Deloitte Technology Fast 500™
From Emulate, Inc.
Via Business Wire
Emulate Introduces the Second-Generation Zoë® Culture Module for Replicating Complex Human Biology and Drug Effect
From Emulate, Inc.
Via Business Wire
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market
From Emulate, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.